Literature DB >> 18844636

Onset of ulcerative colitis under treatment with adalimumab.

Antonio Tursi, Antonio Penna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844636     DOI: 10.1111/j.1572-0241.2008.02010_11.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.

Authors:  Marisa Iborra; Javier Pérez-Gisbert; Marta Maia Bosca-Watts; Alicia López-García; Valle García-Sánchez; Antonio López-Sanromán; Esther Hinojosa; Lucía Márquez; Santiago García-López; María Chaparro; Montserrat Aceituno; Margalida Calafat; Jordi Guardiola; Blanca Belloc; Yolanda Ber; Luis Bujanda; Belén Beltrán; Cristina Rodríguez-Gutiérrez; Jesús Barrio; José Luis Cabriada; Montserrat Rivero; Raquel Camargo; Manuel van Domselaar; Albert Villoria; Hugo Salata Schuterman; David Hervás; Pilar Nos
Journal:  J Gastroenterol       Date:  2016-10-08       Impact factor: 7.527

2.  Adalimumab in ulcerative colitis: two cases of mucosal healing and clinical response at two years.

Authors:  Manuel Barreiro-de Acosta; Aurelio Lorenzo; Juan Enrique Dominguez-Muñoz
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

Review 3.  Colitis associated with biological agents.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

Review 4.  Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab.

Authors:  Hugh J Freeman
Journal:  Ther Clin Risk Manag       Date:  2013-11-07       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.